These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 24047815

  • 1. [Advances in venous thromboembolism].
    Qin L, Lu WX.
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 May; 36(5):372-4. PubMed ID: 24047815
    [No Abstract] [Full Text] [Related]

  • 2. Venous thromboembolism: EINSTEIN transforms anticoagulant therapy in acute PE.
    Kline JA, Yealy DM.
    Nat Rev Cardiol; 2012 May 08; 9(7):378-80. PubMed ID: 22566060
    [No Abstract] [Full Text] [Related]

  • 3. [Therapy of pulmonary embolism. Rivaroxaban is superior to standard therapy].
    Einecke D.
    MMW Fortschr Med; 2012 Apr 19; 154(7):24. PubMed ID: 22558862
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Rivaroxaban and false positive lupus anticoagulant testing.
    Merriman E, Kaplan Z, Butler J, Malan E, Gan E, Tran H.
    Thromb Haemost; 2011 Feb 19; 105(2):385-6. PubMed ID: 21103666
    [No Abstract] [Full Text] [Related]

  • 9. New oral anticoagulants for the treatment of venous thromboembolism.
    Agnelli G, Becattini C, Franco L.
    Best Pract Res Clin Haematol; 2013 Jun 19; 26(2):151-61. PubMed ID: 23953903
    [Abstract] [Full Text] [Related]

  • 10. Oral rivaroxaban for symptomatic venous thromboembolism.
    Landman GW, Gans RO.
    N Engl J Med; 2011 Mar 24; 364(12):1178; author reply 1178. PubMed ID: 21428778
    [No Abstract] [Full Text] [Related]

  • 11. Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis.
    Alotaibi G, Alsaleh K, Wu C, Mcmurtry MS.
    Int Angiol; 2014 Aug 24; 33(4):301-8. PubMed ID: 25056161
    [Abstract] [Full Text] [Related]

  • 12. [CONKO-011: Evaluation of patient satisfaction with the treatment of acute venous thromboembolism with rivaroxaban or low molecular weight heparin in cancer patients. A randomized phase III study].
    Riess H, Sinn M, Kreher S, für den Arbeitskreis Hämostaseologie der Deutschen Gesellschaft für Hämatologie und Medizinische Onkologie (DGHO).
    Dtsch Med Wochenschr; 2015 Jun 24; 140 Suppl 1():S22-3. PubMed ID: 26069043
    [No Abstract] [Full Text] [Related]

  • 13. Rivaroxaban, the first oral, direct factor Xa inhibitor.
    Fassiadis N.
    Expert Opin Pharmacother; 2009 Dec 24; 10(18):2945-6. PubMed ID: 19925048
    [Abstract] [Full Text] [Related]

  • 14. Rivaroxaban for thromboprophylaxis.
    ten Cate H, Hamulyak K.
    N Engl J Med; 2008 Nov 13; 359(20):2174-5; author reply 2176. PubMed ID: 19009676
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sulodexide for the extended treatment of venous thromboembolism.
    Walenga JM, Fareed J, Ramacciotti E.
    Int Angiol; 2016 Dec 13; 35(6):531-533. PubMed ID: 27680735
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Secondary hematoma expansion in intracerebral hemorrhage during rivaroxaban therapy.
    Purrucker JC, Capper D, Behrens L, Veltkamp R.
    Am J Emerg Med; 2014 Aug 13; 32(8):947.e3-5. PubMed ID: 24602898
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.